series-a
Stage
2017
Founded
1
Investors
About
Staten Biotechnology is a clinical-stage biotechnology company focused on developing novel therapeutics for dyslipidemia and associated cardiovascular diseases.
Explore Staten Biotechnology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.